Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

During the Trading Day
4.45 -0.04 / -0.89%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.55 +0.10 / +2.25%
Volume: 1.0K

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +214.61% increase from the last price of 4.45.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.78%
Growthannually 23.53%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account